All News
Year in Review by Dr. Cush and Dr. Kavanaugh
Combo biologic therapy?
Phase II study from GI colleagues for UC
Guselkumab + golimumab
- no additional safety concerns
- improved clinical response
- extrapolate to rheumatology use?
#RNL2023 @RheumNow https://t.co/DirAovm1AX
Robert B Chao, MD doctorRBC ( View Tweet)
✅ RheumNow Live 2023
#RNL2023 @RheumNow
Which adverse events ⬇️ can be expected by patients & their rheumatologists when using #hydroxychloroquine for #Lupus? https://t.co/9zP8aJ4cGq
Laurent ARNAUD Lupusreference ( View Tweet)
TYK2 in plaque psoriasis By Eric Ruderman #RNL2023 @RheumNow
Safer?
No lab monitoring
And it works https://t.co/9Woen2q4hZ
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Beautiful summary of GPA management by Dr.Carol Langford #RNL2023 @RheumNow https://t.co/FCwKN9tovX
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
PMR lab studies by @anisha_dua @RheumNow #RNL2023
Majority of patients will have elevated inflammatory markers.
Rapid clinical response to low dose of steroid. https://t.co/AgdIJ5YbOu
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Some points to consider in relapsing PMR , by @anisha_dua @RheumNow #RNL2023
Elevated ESR and CRP rule out GCA.
Relapses are common with steroid tapering, especially below 5mg. https://t.co/D17mdly7z5
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Long live the GOAT Rx: MTX 🐐🐐
History of usage dating back to 1950
Use 1st-line
Optimize dose
Supplement folic acid
Split dose
Give SQ
Use in combination therapy
Dr Joel Kremer #RNL2023 @RheumNow https://t.co/CCBvQoNHXo
Eric Dein ericdeinmd ( View Tweet)
#ClinicalPearl #Methotrexate weekly May reduce side effects in rapidly dividing cells vs using it daily or every few days. GI, oral, bone marrow side effects should be less if once a week. Joel Kremer @RheumNow #RNL2023 https://t.co/i0LZoQuK0w
Janet Pope Janetbirdope ( View Tweet)
TYK2 signalling Vs JAK signalling summary
#RNL2023 https://t.co/0VNBiEc6jq
Dr Gurdeep Dulay gurdeep_dulay ( View Tweet)
Approach to pregnancy in patients with PsA , By Dr.Chambers #RNL2023 @RheumNow https://t.co/8tSz7qbmQU
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Prevalence of PsA in women of reproductive age, By Dr.Chambers #RNL2023 @RheumNow https://t.co/hB6QQtz7fw
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Dr. Laura Coates on PsA treatment:
- Applying treat to target associated with better quality of life
- low disease activity is a reasonable target
Do you use PROs in managing your PsA pts? Perhaps we should
@RheumNow #RNL2023 https://t.co/36n1Cp5jtP
Robert B Chao, MD doctorRBC ( View Tweet)
Why do PROs matter? @DrLauraCoates reviewed this slide regarding the increased survival curve in end-stage cancer patients when we monitor PROs. @RheumNow #RNL2023 https://t.co/JfHNBKJGRl
Dr. Rachel Tate uptoTate ( View Tweet)
Dr.Robert Spiera approach to GCA #RNL2023 @RheumNow https://t.co/ublzYwBbIF
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Steroid sparing agents in GCA , what worked? By Dr.Robert Spiera #RNL2023 @RheumNow https://t.co/7Q9UYRSAhR
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
PMR by @anisha_dua @RheumNow #RNL2023 https://t.co/mHIBqqRUWh
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
How is a biosimilar approved?
Comparative effectiveness study for the reason that the medication was initial approved required, not for other indications
Jonathan Kay shows ex of ETN-ykro vs reference ETN in RA
Non-inferior in immunogenicity, safety, efficacy
@RheumNow #RNL2023 https://t.co/OOHie9Qr5t
Eric Dein ericdeinmd ( View Tweet)
Great #RNL2023 Plenary with "Miracle Larry" after 128 days in hospital for COVID-19, on 3-year anniversary of going into coma
"I am the expert on what this virus can do. I don't want the world to ever forget"
@RheumNow https://t.co/kTuDXDhTtQ
Eric Dein ericdeinmd ( View Tweet)
Tremendously emotional (and unfiltered) first person account of his fight with COVID-19 by Miracle Larry who thanked our Dr. Cush @RheumNow for his ingenuity in fighting COVID-19, thanking healthcare workers for all they do, and reminding us to be empathic.
#RNL2023 https://t.co/i0D7r8dR8n
Robert B Chao, MD doctorRBC ( View Tweet)
Was amazed at the tons of biosimilar TNF options @_connectedcare uses in Australia... coming soon to the US!
Jonathan Kay #RNL2022 shows the lists of biosimilar
May be w/in batch-to-batch variability, unintended drift, or deliberate process changes (evolution)
@RheumNow https://t.co/sfVQspxbyr
Eric Dein ericdeinmd ( View Tweet)